We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Books
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Lewis K. Antwi
Lewis K. Antwi
Products
PRODUCTS
Baxalta US, Inc.
Lewis K. Antwi
,
Omotunde O. Osunsanmi
, and
Linda Thai
Price:
$117.00
View
Bio-Rad Laboratories, Inc.
Lewis K. Antwi
and
Prabhu P. Raju
Price:
$117.00
View
Novartis Gene Therapies, Inc.
Lewis K. Antwi
,
Steven E. Bowen
, and
Jacqueline M. Diaz Albert
Price:
$117.00
View
D&D Pharma LLC dba MedScript Compounding Pharmacy
Lewis K. Antwi
,
Michael Y. Philopoulos
, and
Charles L. Zhou
Price:
$117.00
View
Upcoming Events
08
Sep
Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections
15
Sep
Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis
20
Sep
Building a World-Class Pharmaceutical Advertising and Promotion Review Program
21
Sep
The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval
22
Sep
FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers
11
Oct
1st Annual Quality Management vSummit
Featured Products
FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485
Selecting and Implementing Electronic Document Management Systems in the EU
Featured Stories
Thermo Fisher Scientific Gets FDA Premarket Approval for Companion Diagnostic
MHRA Grants Conditional Authorization to Moderna’s Bivalent COVID-19 Booster Vaccine
Organogenesis Gets 510(k) Clearance to Expand PuraPly Portfolio
FDA Grants Priority Review to sNDA for Lynparza
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
